1 Introduction to Research & Analysis Reports
1.1 Velpatasvir Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Velpatasvir Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Velpatasvir Overall Market Size
2.1 Global Velpatasvir Market Size: 2022 VS 2029
2.2 Global Velpatasvir Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Velpatasvir Sales: 2018-2029
3 Company Landscape
3.1 Top Velpatasvir Players in Global Market
3.2 Top Global Velpatasvir Companies Ranked by Revenue
3.3 Global Velpatasvir Revenue by Companies
3.4 Global Velpatasvir Sales by Companies
3.5 Global Velpatasvir Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Velpatasvir Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Velpatasvir Product Type
3.8 Tier 1, Tier 2 and Tier 3 Velpatasvir Players in Global Market
3.8.1 List of Global Tier 1 Velpatasvir Companies
3.8.2 List of Global Tier 2 and Tier 3 Velpatasvir Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Velpatasvir Market Size Markets, 2022 & 2029
4.1.2 Above 98.0% Purity
4.1.3 Below 98.0% Purity
4.2 By Type – Global Velpatasvir Revenue & Forecasts
4.2.1 By Type – Global Velpatasvir Revenue, 2018-2023
4.2.2 By Type – Global Velpatasvir Revenue, 2024-2029
4.2.3 By Type – Global Velpatasvir Revenue Market Share, 2018-2029
4.3 By Type – Global Velpatasvir Sales & Forecasts
4.3.1 By Type – Global Velpatasvir Sales, 2018-2023
4.3.2 By Type – Global Velpatasvir Sales, 2024-2029
4.3.3 By Type – Global Velpatasvir Sales Market Share, 2018-2029
4.4 By Type – Global Velpatasvir Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Velpatasvir Market Size, 2022 & 2029
5.1.2 Hepatitis C
5.1.3 Other
5.2 By Application – Global Velpatasvir Revenue & Forecasts
5.2.1 By Application – Global Velpatasvir Revenue, 2018-2023
5.2.2 By Application – Global Velpatasvir Revenue, 2024-2029
5.2.3 By Application – Global Velpatasvir Revenue Market Share, 2018-2029
5.3 By Application – Global Velpatasvir Sales & Forecasts
5.3.1 By Application – Global Velpatasvir Sales, 2018-2023
5.3.2 By Application – Global Velpatasvir Sales, 2024-2029
5.3.3 By Application – Global Velpatasvir Sales Market Share, 2018-2029
5.4 By Application – Global Velpatasvir Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Velpatasvir Market Size, 2022 & 2029
6.2 By Region – Global Velpatasvir Revenue & Forecasts
6.2.1 By Region – Global Velpatasvir Revenue, 2018-2023
6.2.2 By Region – Global Velpatasvir Revenue, 2024-2029
6.2.3 By Region – Global Velpatasvir Revenue Market Share, 2018-2029
6.3 By Region – Global Velpatasvir Sales & Forecasts
6.3.1 By Region – Global Velpatasvir Sales, 2018-2023
6.3.2 By Region – Global Velpatasvir Sales, 2024-2029
6.3.3 By Region – Global Velpatasvir Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Velpatasvir Revenue, 2018-2029
6.4.2 By Country – North America Velpatasvir Sales, 2018-2029
6.4.3 US Velpatasvir Market Size, 2018-2029
6.4.4 Canada Velpatasvir Market Size, 2018-2029
6.4.5 Mexico Velpatasvir Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Velpatasvir Revenue, 2018-2029
6.5.2 By Country – Europe Velpatasvir Sales, 2018-2029
6.5.3 Germany Velpatasvir Market Size, 2018-2029
6.5.4 France Velpatasvir Market Size, 2018-2029
6.5.5 U.K. Velpatasvir Market Size, 2018-2029
6.5.6 Italy Velpatasvir Market Size, 2018-2029
6.5.7 Russia Velpatasvir Market Size, 2018-2029
6.5.8 Nordic Countries Velpatasvir Market Size, 2018-2029
6.5.9 Benelux Velpatasvir Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Velpatasvir Revenue, 2018-2029
6.6.2 By Region – Asia Velpatasvir Sales, 2018-2029
6.6.3 China Velpatasvir Market Size, 2018-2029
6.6.4 Japan Velpatasvir Market Size, 2018-2029
6.6.5 South Korea Velpatasvir Market Size, 2018-2029
6.6.6 Southeast Asia Velpatasvir Market Size, 2018-2029
6.6.7 India Velpatasvir Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Velpatasvir Revenue, 2018-2029
6.7.2 By Country – South America Velpatasvir Sales, 2018-2029
6.7.3 Brazil Velpatasvir Market Size, 2018-2029
6.7.4 Argentina Velpatasvir Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Velpatasvir Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Velpatasvir Sales, 2018-2029
6.8.3 Turkey Velpatasvir Market Size, 2018-2029
6.8.4 Israel Velpatasvir Market Size, 2018-2029
6.8.5 Saudi Arabia Velpatasvir Market Size, 2018-2029
6.8.6 UAE Velpatasvir Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan Laboratories
7.1.1 Mylan Laboratories Company Summary
7.1.2 Mylan Laboratories Business Overview
7.1.3 Mylan Laboratories Velpatasvir Major Product Offerings
7.1.4 Mylan Laboratories Velpatasvir Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Laboratories Key News & Latest Developments
7.2 Century Pharmaceuticals
7.2.1 Century Pharmaceuticals Company Summary
7.2.2 Century Pharmaceuticals Business Overview
7.2.3 Century Pharmaceuticals Velpatasvir Major Product Offerings
7.2.4 Century Pharmaceuticals Velpatasvir Sales and Revenue in Global (2018-2023)
7.2.5 Century Pharmaceuticals Key News & Latest Developments
7.3 PharmaResources (Shanghai)
7.3.1 PharmaResources (Shanghai) Company Summary
7.3.2 PharmaResources (Shanghai) Business Overview
7.3.3 PharmaResources (Shanghai) Velpatasvir Major Product Offerings
7.3.4 PharmaResources (Shanghai) Velpatasvir Sales and Revenue in Global (2018-2023)
7.3.5 PharmaResources (Shanghai) Key News & Latest Developments
8 Global Velpatasvir Production Capacity, Analysis
8.1 Global Velpatasvir Production Capacity, 2018-2029
8.2 Velpatasvir Production Capacity of Key Manufacturers in Global Market
8.3 Global Velpatasvir Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Velpatasvir Supply Chain Analysis
10.1 Velpatasvir Industry Value Chain
10.2 Velpatasvir Upstream Market
10.3 Velpatasvir Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Velpatasvir Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Table 1. Key Players of Velpatasvir in Global Market
Table 2. Top Velpatasvir Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Velpatasvir Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Velpatasvir Revenue Share by Companies, 2018-2023
Table 5. Global Velpatasvir Sales by Companies, (Tons), 2018-2023
Table 6. Global Velpatasvir Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Velpatasvir Price (2018-2023) & (US$/Ton)
Table 8. Global Manufacturers Velpatasvir Product Type
Table 9. List of Global Tier 1 Velpatasvir Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Velpatasvir Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Velpatasvir Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Velpatasvir Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Velpatasvir Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Velpatasvir Sales (Tons), 2018-2023
Table 15. By Type - Global Velpatasvir Sales (Tons), 2024-2029
Table 16. By Application – Global Velpatasvir Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Velpatasvir Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Velpatasvir Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Velpatasvir Sales (Tons), 2018-2023
Table 20. By Application - Global Velpatasvir Sales (Tons), 2024-2029
Table 21. By Region – Global Velpatasvir Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Velpatasvir Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Velpatasvir Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Velpatasvir Sales (Tons), 2018-2023
Table 25. By Region - Global Velpatasvir Sales (Tons), 2024-2029
Table 26. By Country - North America Velpatasvir Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Velpatasvir Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Velpatasvir Sales, (Tons), 2018-2023
Table 29. By Country - North America Velpatasvir Sales, (Tons), 2024-2029
Table 30. By Country - Europe Velpatasvir Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Velpatasvir Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Velpatasvir Sales, (Tons), 2018-2023
Table 33. By Country - Europe Velpatasvir Sales, (Tons), 2024-2029
Table 34. By Region - Asia Velpatasvir Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Velpatasvir Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Velpatasvir Sales, (Tons), 2018-2023
Table 37. By Region - Asia Velpatasvir Sales, (Tons), 2024-2029
Table 38. By Country - South America Velpatasvir Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Velpatasvir Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Velpatasvir Sales, (Tons), 2018-2023
Table 41. By Country - South America Velpatasvir Sales, (Tons), 2024-2029
Table 42. By Country - Middle East & Africa Velpatasvir Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Velpatasvir Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Velpatasvir Sales, (Tons), 2018-2023
Table 45. By Country - Middle East & Africa Velpatasvir Sales, (Tons), 2024-2029
Table 46. Mylan Laboratories Company Summary
Table 47. Mylan Laboratories Velpatasvir Product Offerings
Table 48. Mylan Laboratories Velpatasvir Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 49. Mylan Laboratories Key News & Latest Developments
Table 50. Century Pharmaceuticals Company Summary
Table 51. Century Pharmaceuticals Velpatasvir Product Offerings
Table 52. Century Pharmaceuticals Velpatasvir Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 53. Century Pharmaceuticals Key News & Latest Developments
Table 54. PharmaResources (Shanghai) Company Summary
Table 55. PharmaResources (Shanghai) Velpatasvir Product Offerings
Table 56. PharmaResources (Shanghai) Velpatasvir Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2018-2023)
Table 57. PharmaResources (Shanghai) Key News & Latest Developments
Table 58. Velpatasvir Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2023 (Tons)
Table 59. Global Velpatasvir Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Velpatasvir Production by Region, 2018-2023 (Tons)
Table 61. Global Velpatasvir Production by Region, 2024-2029 (Tons)
Table 62. Velpatasvir Market Opportunities & Trends in Global Market
Table 63. Velpatasvir Market Drivers in Global Market
Table 64. Velpatasvir Market Restraints in Global Market
Table 65. Velpatasvir Raw Materials
Table 66. Velpatasvir Raw Materials Suppliers in Global Market
Table 67. Typical Velpatasvir Downstream
Table 68. Velpatasvir Downstream Clients in Global Market
Table 69. Velpatasvir Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Velpatasvir Segment by Type in 2022
Figure 2. Velpatasvir Segment by Application in 2022
Figure 3. Global Velpatasvir Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Velpatasvir Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Velpatasvir Revenue, 2018-2029 (US$, Mn)
Figure 7. Velpatasvir Sales in Global Market: 2018-2029 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Velpatasvir Revenue in 2022
Figure 9. By Type - Global Velpatasvir Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Velpatasvir Revenue Market Share, 2018-2029
Figure 11. By Type - Global Velpatasvir Sales Market Share, 2018-2029
Figure 12. By Type - Global Velpatasvir Price (US$/Ton), 2018-2029
Figure 13. By Application - Global Velpatasvir Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Velpatasvir Revenue Market Share, 2018-2029
Figure 15. By Application - Global Velpatasvir Sales Market Share, 2018-2029
Figure 16. By Application - Global Velpatasvir Price (US$/Ton), 2018-2029
Figure 17. By Region - Global Velpatasvir Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Velpatasvir Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Velpatasvir Revenue Market Share, 2018-2029
Figure 20. By Region - Global Velpatasvir Sales Market Share, 2018-2029
Figure 21. By Country - North America Velpatasvir Revenue Market Share, 2018-2029
Figure 22. By Country - North America Velpatasvir Sales Market Share, 2018-2029
Figure 23. US Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Velpatasvir Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Velpatasvir Sales Market Share, 2018-2029
Figure 28. Germany Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 29. France Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Velpatasvir Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Velpatasvir Sales Market Share, 2018-2029
Figure 37. China Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 41. India Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Velpatasvir Revenue Market Share, 2018-2029
Figure 43. By Country - South America Velpatasvir Sales Market Share, 2018-2029
Figure 44. Brazil Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Velpatasvir Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Velpatasvir Sales Market Share, 2018-2029
Figure 48. Turkey Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Velpatasvir Revenue, (US$, Mn), 2018-2029
Figure 52. Global Velpatasvir Production Capacity (Tons), 2018-2029
Figure 53. The Percentage of Production Velpatasvir by Region, 2022 VS 2029
Figure 54. Velpatasvir Industry Value Chain
Figure 55. Marketing Channels
※参考情報 ベルパタスビル(Velpatasvir)は、主にC型肝炎ウイルス(HCV)の治療に用いられる抗ウイルス薬です。この薬は、特にHCVの複雑な遺伝的背景を持つ患者に対する治療において重要な役割を果たしています。ベルパタスビルは、インペグルワン(ダスビル)と組み合わせて用いられることが多く、これにより、より高い治癒率が実現されています。 まず、ベルパタスビルの基本的な定義を見ていきましょう。この薬は、HCVの複製を阻害する作用を持つNS5A阻害薬に分類されます。NS5Aはウイルスの複製に必要なタンパク質の一種であり、ベルパタスビルはこのタンパク質の機能を阻害することで、ウイルスの増殖を抑えることに寄与します。この特性により、ベルパタスビルはC型肝炎の治療における重要な治療選択肢とされています。 ベルパタスビルの特徴として、一つには非常に広範囲なHCVのジェノタイプに対する効果があります。HCVには6つの主要なジェノタイプがあり、それぞれがさらにいくつかのサブタイプに分かれていますが、ベルパタスビルはこれらの多くのジェノタイプに対して効果を示します。これにより、さまざまな患者に対応できる汎用性が高い薬剤となっています。 服用方法についても、ベルパタスビルは比較的簡単に使用することができます。通常、経口投与され、1日1回の服用が推奨されています。これにより、患者が治療を遵守しやすい環境が整えられています。また、多くの研究において、ベルパタスビルを含む治療法は比較的副作用が少ないことが確認されています。一般的な副作用としては、倦怠感、頭痛、吐き気などがありますが、重篤な副作用は少なく、患者にとって受け入れやすい薬剤とされています。 さらに、ベルパタスビルは、他の抗HCV薬と組み合わせることで治療効果を高めることができます。例えば、ダスビルとの組み合わせにより、多くの患者において治癒率が90%以上に達することが知られています。このような組み合わせ療法は、既存の治療法に比べて成功率を大幅に向上させる可能性があるため、臨床現場でも積極的に使用されています。 医療現場におけるベルパタスビルの使われ方はさまざまであり、慢性C型肝炎の治療に資する重要な選択肢となっています。また、肝炎ウイルスに感染した患者は、重篤な肝疾患に進展する可能性があり、これを早期に治療することが求められます。ベルパタスビルは、これらの患者に対し、より良い治療結果をもたらすことが期待されています。 関連技術についても触れておく必要があります。ベルパタスビルが登場する背景には、近年のバイオ医薬品の進展があります。特に、ウイルスの遺伝子情報を基にした新薬の開発が進んでおり、これによりHCV治療の選択肢が大幅に拡がりました。また、プロテアーゼ阻害薬やポリメラーゼ阻害薬との併用療法も進められており、これがさらなる治療効果の向上を可能にしています。 ベルパタスビルの開発には、様々な臨床試験が実施されました。これらの試験を通じて、その安全性や有効性が確認され、多くの国で承認されるに至りました。現在、ベルパタスビルは世界中で広く使用されており、その効果が実践において証明されています。 また、ベルパタスビルが持つ経済的な意義も重要です。C型肝炎は未治療の場合、慢性的な肝疾患や肝癌へ進行する可能性が高く、社会的な負担も大きいです。しかし、ベルパタスビルを用いた治療により、これらの病気を予防することができれば、医療費の削減や労働力の損失を防ぐことに寄与します。 最後に、ベルパタスビルの将来的な展望について考えてみましょう。今後もC型肝炎に対する新たな治療法の開発は続くと予想されていますが、ベルパタスビルの効果的な治療法としての地位は揺るがないと考えられます。また、他のウイルス性肝炎に対する応用も検討されており、さらなる研究が期待されています。今後の研究によって、より効果的で安全な治療法が見つかることを願っています。 今回の説明を通じて、ベルパタスビルがC型肝炎の治療において果たす役割、その特徴、関連技術などについて詳しく知ることができたでしょう。今後もこの分野の研究が進展し、より多くの患者に希望を与えることができることを期待しています。 |
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer